Overview

Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

Status:
Unknown status

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to prove the efficacy of the dexamethasone 0.5 mg + 1 mg clemastine fumarate tablet compared to 0.5 mg of dexamethasone in reducing the signs and symptoms of allergic dermatitis.

Phase:

Phase 3

Details

Lead Sponsor:

Azidus Brasil

Treatments:

BB 1101
Clemastine
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate